1. Once a day administration of R(+) propranolol is sufficient to block vasculogenesis in a xenograft model of infantile hemangioma; Jan 27, 2025; pubmed:39866206. View Once a day administration of R(+) propranolol is sufficient to block vasculogenesis in a xenograft model of infantile hemangioma on PubMed
  2. Intravital Imaging of Disease Mechanisms in a Mouse Model of CCM Skin Lesions-Brief Report; Nov 21, 2024; pubmed:39569520. View Intravital Imaging of Disease Mechanisms in a Mouse Model of CCM Skin Lesions-Brief Report on PubMed
  3. R(+) Propranolol decreases lipid accumulation in haemangioma-derived stem cells; Nov 20, 2024; pubmed:39565162. View R(+) Propranolol decreases lipid accumulation in haemangioma-derived stem cells on PubMed
  4. Similarities and differences between brain and skin GNAQ p.R183Q driven capillary malformations; Sep 29, 2024; pubmed:39343803. View Similarities and differences between brain and skin GNAQ p.R183Q driven capillary malformations on PubMed
  5. Novel Role of Endothelial CD45 in Regulating Endothelial-to-Mesenchymal Transition in Atherosclerosis; Sep 16, 2024; pubmed:39282400. View Novel Role of Endothelial CD45 in Regulating Endothelial-to-Mesenchymal Transition in Atherosclerosis on PubMed
  6. An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangioma; Jul 19, 2024; pubmed:39026886. View An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangioma on PubMed
  7. R(+) Propranolol decreases lipid accumulation in hemangioma-derived stem cells; Jul 15, 2024; pubmed:39005472. View R(+) Propranolol decreases lipid accumulation in hemangioma-derived stem cells on PubMed
  8. Similarities and differences between brain and skin <em>GNAQ</em> p.R183Q driven capillary malformations; Jul 1, 2024; pubmed:38948880. View Similarities and differences between brain and skin <em>GNAQ</em> p.R183Q driven capillary malformations on PubMed
  9. Corrigendum to "Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis" [Vascular Pharmacology 155 (2024) 107368]; Apr 24, 2024; pubmed:38658307. View Corrigendum to "Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis" [Vascular Pharmacology 155 (2024) 107368] on PubMed
  10. Infantile hemangioma: the common and enigmatic vascular tumor; Apr 15, 2024; pubmed:38618963. View Infantile hemangioma: the common and enigmatic vascular tumor on PubMed
  11. Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis; Mar 28, 2024; pubmed:38548093. View Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis on PubMed
  12. MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome; Mar 27, 2024; pubmed:38532508. View MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome on PubMed
  13. PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves; Aug 9, 2023; pubmed:37555328. View PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves on PubMed
  14. Arteriovenous malformation Map2k1 mutation affects vasculogenesis; Jul 8, 2023; pubmed:37422456. View Arteriovenous malformation Map2k1 mutation affects vasculogenesis on PubMed
  15. CD45 Is Sufficient to Initiate Endothelial-to-Mesenchymal Transition in Human Endothelial Cells-Brief Report; Mar 16, 2023; pubmed:36924233. View CD45 Is Sufficient to Initiate Endothelial-to-Mesenchymal Transition in Human Endothelial Cells-Brief Report on PubMed
  16. Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis; Jan 2, 2023; pubmed:36591786. View Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis on PubMed
  17. Novel Target for Limiting VEGF-A (Vascular Endothelial Growth Factor A)-Induced Vascular Permeability; Aug 25, 2022; pubmed:36004641. View Novel Target for Limiting VEGF-A (Vascular Endothelial Growth Factor A)-Induced Vascular Permeability on PubMed
  18. Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <em>N</em>-of-1 clinical trial; Jul 5, 2022; pubmed:35787784. View Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <em>N</em>-of-1 clinical trial on PubMed
  19. Wnt Site Signaling Inhibitor Secreted Frizzled-Related Protein 3 Protects Mitral Valve Endothelium From Myocardial Infarction-Induced Endothelial-to-Mesenchymal Transition; Mar 29, 2022; pubmed:35348006. View Wnt Site Signaling Inhibitor Secreted Frizzled-Related Protein 3 Protects Mitral Valve Endothelium From Myocardial Infarction-Induced Endothelial-to-Mesenchymal Transition on PubMed
  20. Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma; Dec 7, 2021; pubmed:34874911. View Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma on PubMed
  21. Endothelial <em>GNAQ</em> p.R183Q Increases ANGPT2 (Angiopoietin-2) and Drives Formation of Enlarged Blood Vessels; Oct 21, 2021; pubmed:34670408. View Endothelial <em>GNAQ</em> p.R183Q Increases ANGPT2 (Angiopoietin-2) and Drives Formation of Enlarged Blood Vessels on PubMed
  22. Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients; Aug 30, 2021; pubmed:34458332. View Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients on PubMed
  23. Endothelial-Mesenchymal Transition in Cardiovascular Disease; Jul 1, 2021; pubmed:34196216. View Endothelial-Mesenchymal Transition in Cardiovascular Disease on PubMed
  24. Isolation of Stem Cells, Endothelial Cells and Pericytes from Human Infantile Hemangioma; Mar 3, 2021; pubmed:33654720. View Isolation of Stem Cells, Endothelial Cells and Pericytes from Human Infantile Hemangioma on PubMed
  25. NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma; Jan 5, 2021; pubmed:33400686. View NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma on PubMed
  26. Epsin-mediated degradation of IP3R1 fuels atherosclerosis; Aug 10, 2020; pubmed:32770009. View Epsin-mediated degradation of IP3R1 fuels atherosclerosis on PubMed
  27. Attenuated Mitral Leaflet Enlargement Contributes to Functional Mitral Regurgitation After Myocardial Infarction; Feb 1, 2020; pubmed:32000951. View Attenuated Mitral Leaflet Enlargement Contributes to Functional Mitral Regurgitation After Myocardial Infarction on PubMed
  28. Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants; Jan 8, 2020; pubmed:31909475. View Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants on PubMed
  29. Oxygen sensing decoded: a Nobel concept in biology; Nov 2, 2019; pubmed:31673842. View Oxygen sensing decoded: a Nobel concept in biology on PubMed
  30. R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma; Jul 31, 2019; pubmed:31358114. View R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma on PubMed
  31. Endothelial-to-Mesenchymal Transition; Apr 12, 2019; pubmed:30973806. View Endothelial-to-Mesenchymal Transition on PubMed
  32. A somatic missense mutation in GNAQ causes capillary malformation; Mar 15, 2019; pubmed:30870248. View A somatic missense mutation in GNAQ causes capillary malformation on PubMed
  33. Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation; Jan 1, 2019; pubmed:30595089. View Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation on PubMed
  34. Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma; Nov 14, 2018; pubmed:30422215. View Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma on PubMed
  35. Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development; Oct 6, 2018; pubmed:30288957. View Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development on PubMed
  36. Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes; Aug 14, 2018; pubmed:30102256. View Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes on PubMed
  37. Consensus guidelines for the use and interpretation of angiogenesis assays; May 17, 2018; pubmed:29766399. View Consensus guidelines for the use and interpretation of angiogenesis assays on PubMed
  38. PTEN (Phosphatase and Tensin Homolog) Connection in Hereditary Hemorrhagic Telangiectasia 2; Apr 27, 2018; pubmed:29695532. View PTEN (Phosphatase and Tensin Homolog) Connection in Hereditary Hemorrhagic Telangiectasia 2 on PubMed
  39. Mitral Valve Adaptation: Can We Win the Race?; Apr 8, 2018; pubmed:29626080. View Mitral Valve Adaptation: Can We Win the Race? on PubMed
  40. Mitral Valve Adaptation to Isolated Annular Dilation: Insights Into the Mechanism of Atrial Functional Mitral Regurgitation; Dec 18, 2017; pubmed:29248661. View Mitral Valve Adaptation to Isolated Annular Dilation: Insights Into the Mechanism of Atrial Functional Mitral Regurgitation on PubMed
  41. Mitral Leaflet Changes Following Myocardial Infarction: Clinical Evidence for Maladaptive Valvular Remodeling; Oct 19, 2017; pubmed:29042413. View Mitral Leaflet Changes Following Myocardial Infarction: Clinical Evidence for Maladaptive Valvular Remodeling on PubMed
  42. Effect of Losartan on Mitral Valve Changes After Myocardial Infarction; Sep 2, 2017; pubmed:28859786. View Effect of Losartan on Mitral Valve Changes After Myocardial Infarction on PubMed
  43. Endothelial colony forming cells and mesenchymal progenitor cells form blood vessels and increase blood flow in ischemic muscle; Apr 12, 2017; pubmed:28396600. View Endothelial colony forming cells and mesenchymal progenitor cells form blood vessels and increase blood flow in ischemic muscle on PubMed
  44. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth; Jan 26, 2017; pubmed:28120216. View A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth on PubMed
  45. Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome; Dec 7, 2016; pubmed:27919468. View Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome on PubMed
  46. EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells; Nov 3, 2016; pubmed:27803106. View EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells on PubMed
  47. CD45 Expression in Mitral Valve Endothelial Cells After Myocardial Infarction; Oct 21, 2016; pubmed:27750208. View CD45 Expression in Mitral Valve Endothelial Cells After Myocardial Infarction on PubMed
  48. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma; Jun 4, 2016; pubmed:27259057. View Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma on PubMed
  49. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma; Apr 9, 2016; pubmed:27058448. View Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma on PubMed
  50. 3D Ultrasound: seeing is understanding-from imaging to pathophysiology to developing therapies in secondary MR; Mar 16, 2016; pubmed:26976355. View 3D Ultrasound: seeing is understanding-from imaging to pathophysiology to developing therapies in secondary MR on PubMed
  51. Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma; Mar 10, 2016; pubmed:26957058. View Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma on PubMed
  52. Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve; Jan 23, 2016; pubmed:26796392. View Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve on PubMed
  53. Endoglin regulates mural cell adhesion in the circulatory system; Dec 10, 2015; pubmed:26646071. View Endoglin regulates mural cell adhesion in the circulatory system on PubMed
  54. Dual role of fatty acid-binding protein 5 on endothelial cell fate: a potential link between lipid metabolism and angiogenic responses; Dec 3, 2015; pubmed:26625874. View Dual role of fatty acid-binding protein 5 on endothelial cell fate: a potential link between lipid metabolism and angiogenic responses on PubMed
  55. Mitral valve disease--morphology and mechanisms; Oct 21, 2015; pubmed:26483167. View Mitral valve disease--morphology and mechanisms on PubMed
  56. Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations; Sep 15, 2015; pubmed:26368330. View Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations on PubMed
  57. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects; Aug 11, 2015; pubmed:26258417. View Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects on PubMed
  58. Valvular interstitial cells suppress calcification of valvular endothelial cells; Aug 2, 2015; pubmed:26232165. View Valvular interstitial cells suppress calcification of valvular endothelial cells on PubMed
  59. Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins; Jun 19, 2015; pubmed:26086095. View Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins on PubMed
  60. Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells; Jun 12, 2015; pubmed:26062754. View Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells on PubMed
  61. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis; May 20, 2015; pubmed:25989290. View The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis on PubMed
  62. Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation; Jan 31, 2015; pubmed:25633835. View Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation on PubMed
  63. The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells; Jan 1, 2015; pubmed:25550468. View The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells on PubMed
  64. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation; Nov 27, 2014; pubmed:25424831. View AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation on PubMed
  65. Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding; Sep 23, 2014; pubmed:25244320. View Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding on PubMed
  66. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells; Sep 5, 2014; pubmed:25187207. View Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells on PubMed
  67. Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway; Aug 9, 2014; pubmed:25103869. View Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway on PubMed
  68. Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK; Mar 18, 2014; pubmed:24632204. View Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK on PubMed
  69. Endothelial PGC-1α mediates vascular dysfunction in diabetes; Feb 11, 2014; pubmed:24506866. View Endothelial PGC-1α mediates vascular dysfunction in diabetes on PubMed
  70. α6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cells; Sep 12, 2013; pubmed:24022922. View α6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cells on PubMed
  71. Rapid onset of perfused blood vessels after implantation of ECFCs and MPCs in collagen, PuraMatrix and fibrin provisional matrices; Aug 20, 2013; pubmed:23955835. View Rapid onset of perfused blood vessels after implantation of ECFCs and MPCs in collagen, PuraMatrix and fibrin provisional matrices on PubMed
  72. Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats; May 14, 2013; pubmed:23666122. View Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats on PubMed
  73. miR-21 represses Pdcd4 during cardiac valvulogenesis; Apr 13, 2013; pubmed:23578931. View miR-21 represses Pdcd4 during cardiac valvulogenesis on PubMed
  74. Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1; Jan 5, 2013; pubmed:23288163. View Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1 on PubMed
  75. Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis; Nov 22, 2012; pubmed:23170111. View Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis on PubMed
  76. E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma; Oct 9, 2012; pubmed:23041613. View E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma on PubMed
  77. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor; Jan 10, 2012; pubmed:22229118. View Infantile hemangioma-mechanism(s) of drug action on a vascular tumor on PubMed
  78. Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells; Jan 7, 2012; pubmed:22223475. View Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells on PubMed
  79. Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve; Nov 30, 2011; pubmed:22123981. View Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve on PubMed
  80. Bioengineered human vascular networks transplanted into secondary mice reconnect with the host vasculature and re-establish perfusion; Nov 1, 2011; pubmed:22039257. View Bioengineered human vascular networks transplanted into secondary mice reconnect with the host vasculature and re-establish perfusion on PubMed
  81. VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma; Sep 28, 2011; pubmed:21945324. View VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma on PubMed
  82. Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma; Sep 23, 2011; pubmed:21938011. View Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma on PubMed
  83. Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations; Sep 17, 2011; pubmed:21921738. View Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations on PubMed
  84. Expression of HES and HEY genes in infantile hemangiomas; Aug 13, 2011; pubmed:21834989. View Expression of HES and HEY genes in infantile hemangiomas on PubMed
  85. Progenitor cells confer plasticity to cardiac valve endothelium; Jul 27, 2011; pubmed:21789724. View Progenitor cells confer plasticity to cardiac valve endothelium on PubMed
  86. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation; Jul 16, 2011; pubmed:21757656. View JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation on PubMed
  87. Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks; Mar 18, 2011; pubmed:21413157. View Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks on PubMed
  88. Mitral valve endothelial cells with osteogenic differentiation potential; Dec 18, 2010; pubmed:21164078. View Mitral valve endothelial cells with osteogenic differentiation potential on PubMed
  89. Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression; Sep 28, 2010; pubmed:20872175. View Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression on PubMed
  90. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells; Mar 19, 2010; pubmed:20237346. View Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells on PubMed
  91. Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo; Mar 12, 2010; pubmed:20218762. View Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo on PubMed
  92. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma; Jan 14, 2010; pubmed:20069356. View A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma on PubMed
  93. Differential functions of genes regulated by VEGF-NFATc1 signaling pathway in the migration of pulmonary valve endothelial cells; Nov 17, 2009; pubmed:19914243. View Differential functions of genes regulated by VEGF-NFATc1 signaling pathway in the migration of pulmonary valve endothelial cells on PubMed
  94. Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study; Sep 16, 2009; pubmed:19751103. View Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study on PubMed
  95. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves; Aug 25, 2009; pubmed:19698056. View Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves on PubMed
  96. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells; Jul 24, 2009; pubmed:19625659. View Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells on PubMed
  97. Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation; Jul 15, 2009; pubmed:19597052. View Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation on PubMed
  98. Vasculogenesis in infantile hemangioma; May 12, 2009; pubmed:19430954. View Vasculogenesis in infantile hemangioma on PubMed
  99. Progenitor cells in infantile hemangioma; Jan 27, 2009; pubmed:19169153. View Progenitor cells in infantile hemangioma on PubMed
  100. Chapter 13. An in vivo experimental model for postnatal vasculogenesis; Nov 22, 2008; pubmed:19022065. View Chapter 13. An in vivo experimental model for postnatal vasculogenesis on PubMed